NCT06614790 Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study. Status RECRUITING Phase N/A
NCT06613230 Improved Early Diagnosis in Female Pelvic Cancer With OC Detect Status COMPLETED Phase N/A
NCT06611072 OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study Status RECRUITING Phase NA
NCT06594679 A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL) Status RECRUITING Phase PHASE1/PHASE2
NCT06588322 Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy Status RECRUITING Phase NA
NCT06586957 A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06582849 Enhanced Assistance During Radiotherapy for Unmet Essential Needs Status COMPLETED Phase NA
NCT06582017 Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma Status RECRUITING Phase PHASE1
NCT06580002 Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial Status RECRUITING Phase PHASE2
NCT06574763 Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06572735 Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer Status RECRUITING Phase N/A
NCT06562647 SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors Status RECRUITING Phase NA
NCT06558019 Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence Status NOT_YET_RECRUITING Phase N/A
NCT06552858 Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06545942 Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06545604 Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer Status RECRUITING Phase NA
NCT06544460 Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients Status NOT_YET_RECRUITING Phase PHASE2
NCT06543537 Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer Status RECRUITING Phase NA